Biomerica Inc (BMRA)
0.3558
-0.01
(-2.12%)
USD |
NASDAQ |
Nov 14, 16:00
0.3558
0.00 (0.00%)
After-Hours: 18:33
Biomerica Enterprise Value: 3.295M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 3.295M |
| November 12, 2024 | 3.404M |
| November 11, 2024 | 3.712M |
| November 08, 2024 | 3.740M |
| November 07, 2024 | 3.552M |
| November 06, 2024 | 3.185M |
| November 05, 2024 | 3.142M |
| November 04, 2024 | 3.152M |
| November 01, 2024 | 3.438M |
| October 31, 2024 | 3.438M |
| October 30, 2024 | 3.392M |
| October 29, 2024 | 2.412M |
| October 28, 2024 | 2.445M |
| October 25, 2024 | 2.142M |
| October 24, 2024 | 2.188M |
| October 23, 2024 | 2.344M |
| October 22, 2024 | 2.613M |
| October 21, 2024 | 2.647M |
| October 18, 2024 | 2.581M |
| October 17, 2024 | 2.882M |
| October 16, 2024 | 3.068M |
| October 15, 2024 | 2.581M |
| October 14, 2024 | 2.899M |
| October 11, 2024 | 2.664M |
| October 10, 2024 | 2.413M |
| Date | Value |
|---|---|
| October 09, 2024 | 2.728M |
| October 08, 2024 | 2.512M |
| October 07, 2024 | 2.450M |
| October 04, 2024 | 2.647M |
| October 03, 2024 | 2.731M |
| October 02, 2024 | 2.984M |
| October 01, 2024 | 2.866M |
| September 30, 2024 | 2.691M |
| September 27, 2024 | 2.479M |
| September 26, 2024 | 2.731M |
| September 25, 2024 | 2.955M |
| September 24, 2024 | 2.984M |
| September 23, 2024 | 2.226M |
| September 20, 2024 | 1.900M |
| September 19, 2024 | 2.514M |
| September 18, 2024 | 2.344M |
| September 17, 2024 | 2.714M |
| September 16, 2024 | 2.586M |
| September 13, 2024 | 2.277M |
| September 12, 2024 | 2.312M |
| September 11, 2024 | 2.412M |
| September 10, 2024 | 2.630M |
| September 09, 2024 | 3.152M |
| September 06, 2024 | 3.017M |
| September 05, 2024 | 3.708M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.4576M
Minimum
Aug 05 2024
162.62M
Maximum
Mar 19 2020
37.74M
Average
36.96M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 378.39M |
| Retractable Technologies Inc | -19.60M |
| InfuSystems Holdings Inc | 217.48M |
| Xtant Medical Holdings Inc | 92.99M |
| Catheter Precision Inc | 1.980M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.316M |
| Revenue (Quarterly) | 1.807M |
| Total Expenses (Quarterly) | 3.175M |
| EPS Diluted (Quarterly) | -0.08 |
| Gross Profit Margin (Quarterly) | 15.99% |
| Profit Margin (Quarterly) | -72.83% |
| Earnings Yield | -104.0% |
| Normalized Earnings Yield | -103.99 |